Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital
,
Abstract
Background: Proton pump inhibitors (PPIs) are one of the most frequently prescribed class of drugs worldwide contributing to the increase in economic burden on the healthcare system. To study the utilization of intravenous proton-pump-inhibitors (PPIs) according to its indications, comorbidities and related pharmacoeconomics in a tertiary care teaching hospital Methods: A prospective-observational study was conducted over 3 months. Case-records of 300 indoor patients were reviewed for IV (intravenous) pantoprazole prescription, as it was the only PPI available at the hospital in IV as well as oral formulations and relevant data was procured. Results: Amongst 300 patient records, 72% were males whereas 28% were females and mean age was 41.18 years (S.D. ± 15.91). 37.33% of the patients were prescribed PPIs for Stress ulcer prophylaxis and 62.66% for non-stress ulcer prophylaxis. 62.66% patients were prescribed IV PPIs inappropriately and 74% were found to be potential candidates for oral pantoprazole therapy without affecting patient outcomes. Utilisation of PPIs was found to be 0.87 defined daily dose (DDD)/100 bed days. The cost of administration for intravenous pantoprazole therapy per patient per day accounted to INR 64.34 and that for oral formulation of the same summed up to INR 1.36. The percentage reduction in the cost of administration of PPI therapy per patient in potential candidates for oral PPI therapy was found to be 97.8%. Antimicrobials (36%) were the most common drugs prescribed concomitantly followed by antiemetics (25%). Conclusion: Subtle changes like shifting the patient to oral formulations when clinically permissible can make a significant positive contribution in resource limited settings without negatively impacting patient outcomes. This will effectively reduce the economic burden on the patients and the healthcare system which is of utmost importance in a resource limited setting like tertiary care hospitals.
2. Bahadori A, Peyrovi H, Ashghali-Farahani M, Hajibabaee F, Haghani H. The relationship between nursing leadership and patient satisfaction. Int J Med Res Heal Sci. 2016;5(10):134–41.
3. Machado-Alba J, Fernández A, Castrillón JD, et al. Prescribing patterns and economic costs of proton pump inhibitors in Colombia. Colomb Med. 2013;44(1):13–8.
4.Heidelbaugh JJ, Kim AH, Walker PC. Overutilization of proton-pump inhibitors: What the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–32.
5.Florentin M. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J Nephrol. 2012;1(6):151.
6. Madsen KR, Lorentzen K, Clausen N, Oberg E, Kirkegaard PR, Maymann-Holler N, Møller MH; Danish Society of Intensive Care Medicine; Danish Society of Anesthesiology and Intensive Care Medicine. Guideline for stress ulcer prophylaxis in the intensive care unit. Dan Med J. 2014 Mar;61(3):C4811.
7. Febrina D Permata and Wustari L Mangundjaya. The role of work engagement in the relationship of job autonomy and proactive work behavior for organizational sustainability 2021 IOP Conf. Ser.: Earth Environ. Sci. 716 012055.
8. Perwaiz M. Inappropriate use of intravenous PPI for Stress Ulcer Prophylaxis in an inner city community hospital. J Clin Med Res. 2010;2(5):215–9.
9.Sign test calculator. Available from: https://www.socscistatistics.com/tests/signtest/default.aspx
10.Promoting rational use of medicines World Health Organization. Available from: https://www.who.int/activities/promoting-rational-use-of-medicines
11.D’souza AM, Shastry CS, Mateti UV, Kabekkodu S, Chand S. Drug utilization and evaluation of proton pump inhibitors in general medicine ward of a tertiary care hospital. J Pharm Sci Res. 2019;11(6):2174–9.
12.Kaur S, Rajagopalan S, Kaur N, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in north India. Emerg Med Int. 2014;2014:1–5.
13.Patil R, Aithal S, Hooli TV, HV V. Drug utilisation study of proton pumps inhibitors in inpatients of a tertiary care hospital: a cross-sectional study. Natl J Integr Res Med. 2015;6(5):62–5.
| Files | ||
| Issue | Vol 10, No 3 (Summer 2022) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jpc.v10i3.10791 | |
| Keywords | ||
| Pharmacoeconomics Stress Ulcer Prophylaxis Intravenous Pantoprazole | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
